Related Experiment Videos
Manipulation of the stem cell as a target for hematologic malignancies
K K Ballen1, P S Becker, F M Stewart
1University of Massachusetts Cancer Center, Worcester, USA.
Seminars in Oncology
|October 26, 2000
Summary
Novel stem cell therapies offer new hope for hematologic malignancies like lymphoma and leukemia. Research explores targeting stem cells in murine models and human applications for improved cancer treatment outcomes.
Area of Science:
- Hematology
- Stem Cell Biology
- Cancer Therapy
Background:
- Hematologic malignancies impact over 80,000 US patients annually.
- Conventional chemotherapy cures some, while bone marrow transplantation is an option for others.
- Novel stem cell-targeted therapies are emerging for these conditions.
Purpose of the Study:
- To explore novel stem cell-targeted therapies for hematologic malignancies.
- To review current research in murine models and human applications.
- To discuss the role of the NOD/scid mouse model in bridging basic research and clinical trials.
Main Methods:
- Review of murine models examining engrafting cell phenotype, stem cell competition, allochimerism, and tolerance induction.
- Analysis of human data on stem cell migration, adhesion receptor expression, and gene therapy manipulations.
- Discussion of the NOD/scid mouse model's utility and variability.
Main Results:
- Insights into stem cell behavior and interactions in murine models.
- Understanding of human stem cell dynamics and potential for gene therapy.
- Evaluation of the NOD/scid model's predictive value for clinical outcomes.
Conclusions:
- Stem cell-targeted approaches represent a promising frontier in treating hematologic malignancies.
- The NOD/scid mouse model is crucial for advancing stem cell research towards clinical application.
- Future directions include gene therapy, high-dose cell transplants, and cellular immune therapies.